Dr. Sanchez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4901 Lang Ave NE
Albuquerque, NM 87109Phone+1 505-842-8171
Summary
- Katherine Sanchez is a medical oncologist who specializes in treating breast cancer. She is a native New Mexican who moved back home in 2022 to serve women in the Albuquerque and Gallup communities.
Dr. Sanchez received her undergraduate degree, attended medical school, and completed a post-sophomore fellowship in pathology at the University of New Mexico and completed her Internal medicine residency at Providence Portland Medical Center in Portland, OR. She completed an immuno-oncology fellowship at Providence Cancer Institute, where she focused on the development of testing to predict response to immunotherapy in early-stage breast cancer, research she continues today. She then completed fellowship in Hematology/Oncology and a breast fellowship at Baylor College of Medicine in Houston Texas.
At New Mexico Cancer Center she joined a team of female-physicians who treat breast cancer. She is working to bring clinical trials to NM that provide early access to medications. Beyond clinical trials, she is passionate about partnering with local resources to bring care and community into the cancer center and create an environment of support for breast cancer patients.
Education & Training
- Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterResidency, Internal Medicine, 2015 - 2018
- University of New Mexico School of MedicineClass of 2015
- University of New MexicoB.S., Biology, Chemistry, and Asian Studies, 2005 - 2009
Certifications & Licensure
- NM State Medical License 2022 - 2025
- OR State Medical License 2016 - 2025
- TX State Medical License 2021 - 2025
- WA State Medical License 2018 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Academic Excellence and Achievement Award in Pathology 2014
- Research Recipient New Mexico IDeA Networks of Biomedical Research Excellence (INBRE), 2014
Clinical Trials
- Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab Start of enrollment: 2019 Jan 25
- A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) Start of enrollment: 2022 Nov 28
- A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02) Start of enrollment: 2022 May 16
- Join now to see all
Publications & Presentations
PubMed
- Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center.Emily L Podany, Shaun Bulsara, Katherine Sanchez, Kristen Otte, Matthew J Ellis
NPJ Breast Cancer. 2024-08-03 - The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care.Jan Gryczynski, Katherine Sanchez, Steven B Carswell, Robert P Schwartz
Addiction Science & Clinical Practice. 2023-11-16 - 2 citationsUse of Telehealth Early and Late in the COVID-19 Public Health Emergency: Policy Implications for Improving Health Equity.Katherine Sanchez, Heather Kitzman, Mahbuba Khan, Briget da Graca, Jeffrey Zsohar
Journal of the American Board of Family Medicine. 2023-10-11
Journal Articles
- Immunotherapy in breast cancer: An overview of modern checkpoint blockage strategies and vaccinesSanchez, K.G., Page, D.B., McArthur, H.L., Current problems in cancer, 1/1/2016
- 16s Metagenomic Sequencing Analysis of Gallbladder Cancer Patients in New MexicoGullapalli, RR., Sanchez, K.G., Wu J., Journal of Molecular Diagnostics, 1/1/2015
- 16s Metagenomic Sequencing Method Using Archived FFPE Tissue: An Untapped Resource to Study the Cancer MicrobiomeSanchez, K.G., Wu J., Pomo, J.M., Gullapalli, R.R., Journal of Molecular Diagnostics, 1/1/2015
Abstracts/Posters
- Safety and efficacy of pembrolizumab plus capecitabine in metastatic triple negative breast cancer (mTNBC)Johnson, J., Sanchez, K.G., Jernigan, J., American College of Physicians New Mexico Chapter Scientific Meeting, Chicago, IL, 1/1/2018
- Multispectral immunofluorescence (mIHC) as a novel and complementary method of characterizing tumor infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC)Page, D.B., Sanchez, K.G., Ballesteros-Merino, C., Martel, M., Bifulco, C., Urba, W.,, Fox, B., Society for Immunotherapy of Cancer (SITC) Annual Meeting; Susan G. Komen Oregon & SW Washington Annual Meeting, National Harbor, MD, 2016; Portland, OR, 2017, 1/1/2017
- Headache and confusion, an easily missed presentation of CNS involvement by CLLSanchez, K.G., Southworth, C., James, T., American College of Physicians Oregon Chapter Scientific Meeting, Salem, OR, 1/1/2015
- Join now to see all
Lectures
- Evaluation of immunotherapy (I-O)-associated immune cell (IC) dynamics and PD-L1 expression using multispectral immunohistochemistry (mIHC) and single-cell hierarchica...2019 ASCO Annual Meeting - 6/1/2019
- ASCO Updates: Can immune checkpoint blockade combination therapy improve response rates in breast cancer?Portland, OR - 1/1/2018
- Immune checkpoint combinations for breast cancerPortland, OR - 1/1/2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: